Injectable microspheres
Injectable microspheres are obtained from double bond functionalized polyhydric alcohol ester by a method comprising dissolving the double bond functionalized esters in a hydrophobic organic solvent, forming an aqueous solution of stabilizer, forming an oil in water emulsion where the solution of stabilizer constitutes the continuous phase and the solution of ester constitutes the disperse phase and evaporating the organic solvent or from block copolymer of PGCLM and methoxy poly(ethylene glycol).
1 . A biodegradable microsphere formed from multiarm biodegradable polymers wherein the surface of the microsphere is hydrophilic and comprises unsaturated C═C bonds, wherein said microsphere is formed from a double bond functionalized polyhydric alcohol ester of polyester, and wherein said microsphere can be loaded with at least one bioactive agent.
2 . The microsphere, according to claim 1 , wherein the surface of the microsphere is converted to a hydrogel.
3 . The microsphere, according to claim 2 , comprising a bioactive agent encapsulated in the microsphere, as well as a bioactive agent entrapped within said hydrogel.
4 . A method for preparing a biodegradable microsphere wherein said method comprises
(a) dissolving a double bond functionalized polyhydric alcohol ester of polyester in a hydrophobic organic solvent,
(b) dissolving a stabilizer in water,
(c) admixing the solutions formed in step (a) and step (b) to form an emulsion where the solution formed in step (b) constitutes the continuous phase and the solution formed in step (a) constitutes the disperse phase,
(d) evaporating the organic solvent to form a hardened microsphere by polymer precipitation, from the double bond functionalized polyhydric alcohol ester,
(e) recovering the microsphere.
5 . The method, according to claim 2 , wherein the stabilizer is a polyalcohol.
6 . The method, according to claim 4 , wherein the stabilizer is dextran.
7 . The method, according to claim 4 , wherein the stabilizer is a sucrose ester.
8 . The method of claim 4 where the double bond functionalized polyhydric alcohol ester is obtained by polymerizing ε-caprolactone monomer or a blend of ε-caprolactone monomer and lactide monomer or glycolide monomer in the presence of polyhydric alcohol containing from 3 to 6 hydroxyl groups to form polyhydric alcohol ester where the acyl groups contain free hydroxyl at their terminal ends and reacting with maleic anhydride to convert some or each of the free hydroxyls to moiety containing 2-carboxy ethenyl group.
9 . The method of claim 4 where the double bond functionalized polyhydric alcohol ester is obtained by polymerizing ε-caprolactone monomer in the presence of glycerol to form the polyhydric alcohol ester where the acyl groups contain free hydroxyl at their terminal ends and reacting with maleic anhydride to convert some or each of the free hydroxyls to moiety containing 2-carboxy ethenyl group.
10 . The method of claim 4 where the double bond functionalized polyhydric alcohol ester has a number average molecular weight, M n , ranging from 1,000 to 50,000.
11 . The method of claim 4 where the solvent is one that dissolves the double bond functionalized polyhydric alcohol ester at room temperature and has a boiling point ranging from 30-45° C.
12 . The method of claim 11 where the solvent is dichloromethane.
13 . The method of claim 4 where the volume ratio of solution formed in step (b) to solution formed in step (a) admixed in step (c) ranges from 3:1 to 10:1.
14 . The method of claim 4 where a photoinitiator is included in the solution formed in step (a) and the admixture formed in step (c) is irradiated to obtain photocrosslinking to provide hydrogel surface on disperse phase particles.
15 . The method of claim 4 where water soluble drug or other biologically active agent is dissolved in water to form an aqueous solution which is admixed with solution formed in step (a) to form a water in oil emulsion which is admixed with the solution formed in step (b) to form a water in oil in water emulsion in step (c).
16 . The method of claim 4 where oil soluble drug or other biologically active agent is present in the solution formed in step (a).
17 . The method, according to claim 4 , wherein a double bond functionalized poly (ortho ester) is prepared by the reaction between the diketene acetal 3,9-diethylidene-2,4,8,10tetraoxaspiro[5.5]undecane and 1,10-decanediol or triethylene glycol.
18 . An injectable microsphere having a mean transverse dimension from 5 to 200 μm, formed of a hardened double bond functionalized polyhydric alcohol ester of polyester loaded with from 0.1 to 25% by weight of the microsphere of a drug or other biologically active agent for sustained release after injection of the microsphere where the surface of the micropshere has micropores formed therein.
19 . The injectable microsphere of claim 18 , wherein the double bond functionalized polyhydric alcohol ester of polyester is obtained by polymerizing ε-caprolactone monomer in the presence of glycerol to form polyhydric alcohol ester where the acyl groups contain free hydroxyl at their terminal ends and reacting with maleic anhydride to convert some or each of the free hydroxyls to moiety containing a 2-carboxy ethenyl group.
20 . A drug-loaded microsphere formed from an amphiphilic plural block copolymer where one block is from PGCLM and the other block(s) are from methoxy poly(ethylene glycol), by dissolving the copolymer in organic solvent, adding the drug to the formed solution, then removing free drug and solvent and then drying.